The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010
Open accessAbstract
To determine the epidemiology and trends of invasive fungal infections (IFIs) in France, we analyzed incidence, risk factors, and in-hospital death rates related to the most frequent IFIs registered in the national hospital discharge database during 2001-2010. The identified 35,876 IFI cases included candidemia (43.4%), Pneumocystis jirovecii pneumonia (26.1%), invasive aspergillosis (IA, 23.9%), cryptococcosis (5.2%), and mucormycosis (1.5%). The overall incidence was 5.9/100,000 cases/year and the mortality rate was 27.6%; both increased over the period (+1.5%, +2.9%/year, respectively). Incidences substantially increased for candidemia, IA, and mucormycosis. Pneumocystis jirovecii pneumonia incidence decreased among AIDS patients (-14.3%/year) but increased in non-HIV-infected patients (+13.3%/year). Candidemia and IA incidence was increased among patients with hematologic malignancies (>+4%/year) and those with chronic renal failure (>+10%/year). In-hospital deaths substantially increased in some groups, e.g., in those with hematologic malignancies. IFIs occur among a broad spectrum of non-HIV-infected patients and should be a major public health priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066
Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657
Tackling Human Fungal Infections
Brown, G. D., Denning, D. W., & Levitz, S. M. (2012) · Science · doi:10.1126/science.1222236 · Cited by 619
A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
Lanternier, F., Dannaoui, E., Morizot, G., Elie, C., Garcia-Hermoso, D., Huerre, M., Bitar, D., Dromer, F., Lortholary, O., & the French Mycosis Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir880 · Cited by 527
Self-citationCurrent Epidemiology of Pneumocystis Pneumonia
Morris, A., Lundgren, J. D., Masur, H., Walzer, P. D., Hanson, D. L., Frederick, T., Huang, L., Beard, C. B., & Kaplan, J. E. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1010.030985 · Cited by 450
Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006
Bitar, D., Van Cauteren, D., Lanternier, F., Dannaoui, E., Che, D., Dromer, F., Desenclos, J.-C., & Lortholary, O. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.090334 · Cited by 429
Self-citationRees, J. R., Pinner, R. W., Hajjeh, R. A., Brandt, M. E., & Reingold, A. L. (1998) · Clinical Infectious Diseases · doi:10.1093/clinids/27.5.1138 · Cited by 397
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
Dromer, F., Mathoulin-Pélissier, S., Launay, O., Lortholary, O., & the French Cryptococcosis Study Group (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040021 · Cited by 374
Self-citationNecrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011
Neblett Fanfair, R., Benedict, K., Bos, J., Bennett, S. D., Lo, Y.-C., Adebanjo, T., Etienne, K., Deak, E., Derado, G., Shieh, W.-J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204781 · Cited by 360
Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Alangaden, G. J. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.003 · Cited by 337
Advances and challenges in management of invasive mycoses
Patterson, T. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67381-3 · Cited by 230
Azie, N., Neofytos, D., Pfaller, M., Meier-Kriesche, H.-U., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.06.012 · Cited by 222
Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee
Kainer, M. A., Reagan, D. R., Nguyen, D. B., Wiese, A. D., Wise, M. E., Ward, J., Park, B. J., Kanago, M. L., Baumblatt, J., Schaefer, M. K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1212972 · Cited by 209
Dromer, F., Mathoulin-Pélissier, S., Fontanet, A., Ronin, O., Dupont, B., & Lortholary, O. (2004) · AIDS · doi:10.1097/00002030-200402200-00024 · Cited by 197
Self-citationIncreasing Pneumocystis Pneumonia, England, UK, 2000–2010
Maini, R., Henderson, K. L., Sheridan, E. A., Lamagni, T., Nichols, G., Delpech, V., & Phin, N. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1903.121151 · Cited by 189
Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland
Ásmundsdóttir, L. R., Erlendsdóttir, H., & Gottfredsson, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3489-3492.2002 · Cited by 188
Candidemia in Norway (1991 to 2003): Results from a Nationwide Study
Sandven, P., Bevanger, L., Digranes, A., Haukland, H. H., Mannsåker, T., Gaustad, P., & the Norwegian Yeast Study Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00029-06 · Cited by 173
Burden of aspergillosis-related hospitalizations in the United States
Dasbach, E. J., Davies, G. M., & Teutsch, S. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317487 · Cited by 159
Menzin, J., Meyers, J., Friedman, M., Perfect, J. R., Langston, A. A., Danna, R. P., & Papadopoulos, G. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080325 · Cited by 151
Secular trends in candidemia-related hospitalization in the United States, 2000–2005
Zilberberg, M. D., Shorr, A. F., & Kollef, M. H. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591033 · Cited by 137
Invasive Candida species infections: a 5 year population-based assessment
Laupland, K. B., Gregson, D. B., Church, D. L., Ross, T., & Elsayed, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki258 · Cited by 130
Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990–9)
LAMAGNI, T. L., EVANS, B. G., SHIGEMATSU, M., & JOHNSON, E. M. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005507 · Cited by 104
The changing epidemiology of invasive fungal infections: new threats
Maschmeyer, G. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.006 · Cited by 100
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 93
Horn, D. L., Fishman, J. A., Steinbach, W. J., Anaissie, E. J., Marr, K. A., Olyaei, A. J., Pfaller, M. A., Weiss, M. A., Webster, K. M., & Neofytos, D. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.06.008 · Cited by 88
Al-shair, K., Atherton, G. T., Harris, C. M., Ratcliffe, L., Newton, P. J., & Denning, D. W. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit411 · Cited by 83
Kelley, C. F., Checkley, W., Mannino, D. M., Franco‐Paredes, C., del Rı́o, C., & Holguín, F. (2009) · CHEST Journal · doi:10.1378/chest.08-2859 · Cited by 77
Chang, D. C., Burwell, L. A., Lyon, G. M., Pappas, P. G., Chiller, T. M., Wannemuehler, K. A., Fridkin, S. K., & Park, B. J. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/524324 · Cited by 51
The economic costs to United States hospitals of invasive fungal infections in transplant patients
Menzin, J., Meyers, J. L., Friedman, M., Korn, J. R., Perfect, J. R., Langston, A. A., Danna, R. P., & Papadopoulos, G. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.06.009 · Cited by 48
Bitar, D., Morizot, G., Cauteren, D. V., Dannaoui, É., Lanternier, F., Lortholary, O., & Dromer, F. (2012) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2012.03.007 · Cited by 23
Self-citation
Cited by
Jeong, W., Keighley, C., Wolfe, R., Lee, W. L., Slavin, M. A., Kong, D. C. M., & Chen, S. C.-A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.07.011 · Cited by 1,082
Maertens, J. A., Raad, I. I., Marr, K. A., Patterson, T. F., Kontoyiannis, D. P., Cornely, O. A., Bow, E. J., Rahav, G., Neofytos, D., Aoun, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01159-9 · Cited by 1,001
Self-citationPfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707
Verweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561
Metadata
- Authors
- Bitar, D., Lortholary, O., Le Strat, Y., Nicolau, J., Coignard, B., Tattevin, P., Che, D., & Dromer, F.
- Venue
- Emerging Infectious Diseases
- Published
- 2014-07
- Volume
- 20
- Issue
- 7
- Pages
- 1163-1169
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2151254250
- Cited by
- 426
- References
- 32
- FWCI
- 23.58
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.